AR121340A1 - Derivados de carboxamida heteroaromáticos como inhibidores de calicreína plasmática - Google Patents
Derivados de carboxamida heteroaromáticos como inhibidores de calicreína plasmáticaInfo
- Publication number
- AR121340A1 AR121340A1 ARP210100384A ARP210100384A AR121340A1 AR 121340 A1 AR121340 A1 AR 121340A1 AR P210100384 A ARP210100384 A AR P210100384A AR P210100384 A ARP210100384 A AR P210100384A AR 121340 A1 AR121340 A1 AR 121340A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- plasma
- kallicerein
- inhibitors
- carboxamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20157257 | 2020-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR121340A1 true AR121340A1 (es) | 2022-05-11 |
Family
ID=69591570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100384A AR121340A1 (es) | 2020-02-13 | 2021-02-12 | Derivados de carboxamida heteroaromáticos como inhibidores de calicreína plasmática |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11851418B2 (https=) |
| EP (1) | EP4103561A1 (https=) |
| JP (1) | JP7686002B2 (https=) |
| CN (1) | CN115087652B (https=) |
| AR (1) | AR121340A1 (https=) |
| TW (1) | TW202144331A (https=) |
| WO (1) | WO2021160716A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112839711A (zh) | 2018-10-10 | 2021-05-25 | 勃林格殷格翰国际有限公司 | 作为血浆激肽释放酶抑制剂的苯基四唑衍生物 |
| TWI873290B (zh) | 2020-02-13 | 2025-02-21 | 德商百靈佳殷格翰國際股份有限公司 | 作為血漿激肽釋放酶抑制劑之雜芳族甲醯胺衍生物 |
| TW202144331A (zh) | 2020-02-13 | 2021-12-01 | 德商百靈佳殷格翰國際股份有限公司 | 作為血漿激肽釋放酶抑制劑之雜芳族甲醯胺衍生物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI243164B (en) | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| US20050090529A1 (en) | 2003-07-31 | 2005-04-28 | Pfizer Inc | 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| JP2005089362A (ja) | 2003-09-17 | 2005-04-07 | Sumitomo Chemical Co Ltd | アリールピラゾリン化合物及びその用途 |
| EP2259679A4 (en) | 2008-01-31 | 2011-09-14 | Joslin Diabetes Ct | METHODS OF TREATING KALLIKREIN RELATED DISORDERS |
| EP2807156A1 (en) | 2012-01-27 | 2014-12-03 | Novartis AG | Aminopyridine derivatives as plasma kallikrein inhibitors |
| US20140378474A1 (en) | 2012-01-27 | 2014-12-25 | Novartis Ag | 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| EP2999697B1 (en) | 2013-05-23 | 2017-04-19 | Kalvista Pharmaceuticals Limited | Heterocyclic derivates |
| KR102736869B1 (ko) * | 2014-03-07 | 2024-12-02 | 바이오크리스트파마슈티컬즈,인코포레이티드 | 인간 혈장 칼리크레인 저해제 |
| GB201421083D0 (en) * | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| DK4019022T3 (en) * | 2015-10-01 | 2024-02-19 | Biocryst Pharm Inc | Human plasma kallikrein inhibitors |
| WO2017072020A1 (en) | 2015-10-27 | 2017-05-04 | Boehringer Ingelheim International Gmbh | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| EP3368524B1 (en) | 2015-10-27 | 2021-08-18 | Boehringer Ingelheim International GmbH | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| DK3464271T3 (da) | 2016-05-31 | 2020-06-15 | Kalvista Pharmaceuticals Ltd | Pyrazolderivater som plasma-kallikreininhibitorer |
| CN110022875A (zh) | 2016-07-11 | 2019-07-16 | 莱福斯希医药公司 | 治疗性抑制化合物 |
| US10501440B2 (en) | 2017-04-21 | 2019-12-10 | Boehringer Ingelheim International Gmbh | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| JP6828191B2 (ja) * | 2018-08-16 | 2021-02-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 血漿カリクレイン阻害剤としての複素芳香族カルボキサミド誘導体 |
| DK4031547T3 (da) * | 2019-09-18 | 2024-09-09 | Takeda Pharmaceuticals Co | Plasmakallikreininhibitorer og anvendelser deraf |
| TW202144331A (zh) | 2020-02-13 | 2021-12-01 | 德商百靈佳殷格翰國際股份有限公司 | 作為血漿激肽釋放酶抑制劑之雜芳族甲醯胺衍生物 |
| TWI873290B (zh) | 2020-02-13 | 2025-02-21 | 德商百靈佳殷格翰國際股份有限公司 | 作為血漿激肽釋放酶抑制劑之雜芳族甲醯胺衍生物 |
-
2021
- 2021-02-09 TW TW110104876A patent/TW202144331A/zh unknown
- 2021-02-11 US US17/173,212 patent/US11851418B2/en active Active
- 2021-02-11 EP EP21704539.2A patent/EP4103561A1/en active Pending
- 2021-02-11 WO PCT/EP2021/053284 patent/WO2021160716A1/en not_active Ceased
- 2021-02-11 JP JP2022548997A patent/JP7686002B2/ja active Active
- 2021-02-11 CN CN202180014104.6A patent/CN115087652B/zh active Active
- 2021-02-12 AR ARP210100384A patent/AR121340A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP4103561A1 (en) | 2022-12-21 |
| CN115087652A (zh) | 2022-09-20 |
| CN115087652B (zh) | 2024-05-07 |
| US20210276976A1 (en) | 2021-09-09 |
| JP2023513906A (ja) | 2023-04-04 |
| TW202144331A (zh) | 2021-12-01 |
| WO2021160716A1 (en) | 2021-08-19 |
| JP7686002B2 (ja) | 2025-05-30 |
| US11851418B2 (en) | 2023-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR121340A1 (es) | Derivados de carboxamida heteroaromáticos como inhibidores de calicreína plasmática | |
| DOP2021000038A (es) | COMPUESTOS DE PIRAZOLO[3,4-b]PIRIDINA COMO INHIBIDORES DE CINASAS TAM Y MET | |
| AR127705A1 (es) | Heterociclos inhibidores de nlrp3 | |
| PH12018550202A1 (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| DOP2021000234A (es) | Pirroles triciclicos condensados como moduladores de alfa-1 antitripsina | |
| NI201800093A (es) | Inhibidores de mcl1 macrocíclicos para tratar el cáncer | |
| AR115965A1 (es) | Derivados heteroaromáticos de carboxamida como inhibidores de la calicreína plasmática | |
| CL2023001244A1 (es) | Derivados de carboxamida heteroaromática como inhibidores de la calicreína plasmática | |
| PE20170939A1 (es) | Pirimidinonas como inhibidores del factor xia | |
| NO20090756L (no) | Amino-piperidinderivater som CETP-inhibitorer | |
| DOP2021000077A (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
| UY35617A (es) | Inhibidores de la fosfatidilinositol 3-quinasa | |
| EA201692418A1 (ru) | Замещенные индазольные соединения в качестве irak4 ингибиторов | |
| MX380276B (es) | Inhibidor jak. | |
| PE20190376A1 (es) | Combinaciones farmaceuticas para el tratamiento del cancer | |
| MX2019006612A (es) | Derivados de imidazo[1,5-a]pirazina como inhibidores de fosfatidilinositol-4,5-bisfosfato 3-quinasadelta (pi3kdelta). | |
| CO2023013448A2 (es) | Derivados de morfolinas sustituidas y usos de los mismos | |
| MX2021010131A (es) | Formas sólidas de pirazinas condensadas a manera de inhibidores de syk. | |
| CU20250003A7 (es) | Compuestos de piridinona sustituida como inhibidores de cbl-b | |
| CO2025013218A2 (es) | Derivados de morfolinas sustituidas y usos de estas | |
| MX2024009581A (es) | Compuestos de uracilo n3-sustituidos como inhibidores de trpa1. | |
| MX2020011991A (es) | Inhibidores de la oncoproteina ras, metodos de produccion y metodos de uso de los mismos. | |
| AR129212A1 (es) | Compuestos piridona como inhibidores de trpa1 | |
| CR20220342A (es) | Agentes terapéuticos selectivos contra el cáncer inhibidores cdk4/6 | |
| MX2022004742A (es) | Derivados del acido carboxilico de quinolona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |